Y. Chang

发表

Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors.

P. Schultz, L. Meijer, N. Gray, 1999, Chemistry & biology.

A cyclin-dependent kinase inhibitor inducing cancer cell differentiation: biochemical identification using Xenopus egg extracts.

P G Schultz, P. Schultz, N. Gray, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Recent advances in small molecule microarrays: applications and technology.

Y. Chang, Y T Chang, D. Walsh, 2004, Combinatorial chemistry & high throughput screening.

Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors.

J Mottram, L Meijer, P Grellier, 2000, Chemistry & biology.

Discovery of estrogen sulfotransferase inhibitors from a purine library screen.

N S Gray, P G Schultz, P. Schultz, 2001, Journal of medicinal chemistry.

Synthesis and iron binding studies of myo-inositol 1,2,3-trisphosphate and (+/-)-myo-inositol 1,2-bisphosphate, and iron binding studies of all myo-inositol tetrakisphosphates.

Y. Chang, J. Gardiner, D. Poyner, 1996, Carbohydrate research.

Versatile fluorescence labeling method using activated esters on solid support.

P. Schultz, Y. Chang, 1999, Bioorganic & medicinal chemistry letters.

Recombinant p42IP4, a brain-specific 42-kDa high-affinity Ins(1,3,4,5)P4 receptor protein, specifically interacts with lipid membranes containing Ptd-Ins(3,4,5)P3.

Y. Chang, G. Reiser, J. Falck, 1999, European journal of biochemistry.

Binding and activity of the nine possible regioisomers of myo-inositol tetrakisphosphate at the inositol 1,4,5-trisphosphate receptor.

Y. Chang, N. Burford, S. Nahorski, 1997, Cell calcium.

Tubulyzine, a novel tri-substituted triazine, prevents the early cell death of transplanted myogenic cells and improves transplantation success.

Y. Chang, D. Skuk, E. E. El Fahime, 2003, Biochemistry and cell biology = Biochimie et biologie cellulaire.

A new alternative adsorbent for the removal of cationic dyes from aqueous solution

Y. Chang, V. Vasantha, T. Santhi, 2016 .

Synthesis and characterization of radiation sensitive TiO2/monazite photocatalyst

Y. Chang, Chu‐Fang Wang, Tzu‐Yu Chen, 2008 .

Syntheses of D- and L-myo-inositol 1,2,4,5-tetrakisphosphate and stereoselectivity of the I(1,4,5)P3 receptor binding.

Y. Chang, B. Shin, B. Suh, 1998, Bioorganic & medicinal chemistry letters.

Rapid kinetic measurements of 45Ca2+ mobilization reveal that Ins(2,4,5)P3 is a partial agonist at hepatic InsP3 receptors.

C. Taylor, Y. Chang, J. Marchant, 1997, The Biochemical journal.

Synthesis of all possible regioisomers of scyllo-inositol phosphate.

Y. Chang, S. K. Chung, K. H. Park, 1999, Bioorganic & medicinal chemistry.

Synthesis and biological evaluation of myoseverin derivatives: microtubule assembly inhibitors.

N S Gray, P G Schultz, P. Schultz, 2001, Journal of medicinal chemistry.

Determination of specificity of a high-affinity inositol 1,3,4,5-tetrakisphosphate binding site at a 42 kDa receptor protein, p42IP4: comparison of affinities of all inositoltris-,-tetrakis-, and -pentakisphosphate regioisomers.

Y. Chang, G. Reiser, S. K. Chung, 1996, Biochemical and biophysical research communications.

Computer modeling of 3D structures of cytochrome P450s.

O. Stiffelman, Y. Chang, G. Loew, 1996, Biochimie.

Molecular dynamics simulations of P450 BM3--examination of substrate-induced conformational change.

Y. Chang, G. Loew, 1999, Journal of biomolecular structure & dynamics.

Construction of a 3D model of cytochrome P450 2B4.

G H Loew, I. Vakser, O. Stiffelman, 1997, Protein engineering.